Literature DB >> 9665082

HLA-specific antibodies in highly sensitized patients can cause a positive crossmatch against pig lymphocytes.

C J Taylor1, K G Tang, S I Smith, D J White, H F Davies.   

Abstract

BACKGROUND: The presence of IgG HLA-specific antibodies in the serum of patients awaiting transplantation indicates T- and B-cell priming and would result in acute rejection of a poorly matched human allograft. Recent advances in xenotransplantation, with the amelioration of hyperacute rejection using transgenic pig kidneys, may benefit such patients. However, accelerated cellular rejection might result from the primed T-cell recognition of antigenic epitopes shared between pig and human MHC molecules.
METHODS: We have compared the reactivity of IgG antibodies from 8 nonsensitized (NS) and 13 highly sensitized (HS) patients with human and pig lymphocytes by flow cytometry. Xenoreactive natural antibodies (XNA) were absorbed with pig red blood cells, and HLA class I-specific antibodies were further absorbed with pooled human platelets.
RESULTS: Before XNA absorption, 20 of the 21 patients had a positive IgG crossmatch with pig lymphocytes, and there was no difference between NS and HS patients. In contrast, after XNA absorption, none of the 8 NS patients were positive, compared with 9 of the 13 HS patients (mean of the median channel fluorescence values of 7.7 and 86.5, respectively; P=<0.001). For XNA-absorbed HS patient sera, 20 of 30 (67%) pig lymphocyte crossmatch combinations were positive, with a mean median channel fluorescence value of 125 (range 31 to 294) compared with 9.5 (range 7 to 13) for the 10 crossmatch-negative combinations. Platelet absorption resulted in a concomitant reduction in antibody binding to pig lymphocytes in three of six HS patient sera, indicating that HLA class I-specific antibodies are responsible, at least in part, for the positive crossmatch.
CONCLUSION: These results suggest that some IgG HLA-specific antibodies can bind to pig lymphocytes, analogous to a positive crossmatch with allogeneic donors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665082     DOI: 10.1097/00007890-199806270-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Is sensitization to pig antigens detrimental to subsequent allotransplantation?

Authors:  Qi Li; Hidetaka Hara; Zhongqiang Zhang; Michael E Breimer; Yi Wang; David K C Cooper
Journal:  Xenotransplantation       Date:  2018-04-14       Impact factor: 3.907

Review 2.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

3.  Swine Leukocyte Antigen Class II Is a Xenoantigen.

Authors:  Joseph M Ladowski; Luz M Reyes; Gregory R Martens; James R Butler; Zheng-Yu Wang; Devin E Eckhoff; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

4.  Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells.

Authors:  Zhongqiang Zhang; Hidetaka Hara; Cassandra Long; Hayato Iwase; Haizhi Qi; Camila Macedo; Massimo Mangiola; Adriana Zeevi; Mohamed Ezzelarab; David Ayares; David K C Cooper; Martin Wijkstrom
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

5.  Examining epitope mutagenesis as a strategy to reduce and eliminate human antibody binding to class II swine leukocyte antigens.

Authors:  Joseph M Ladowski; Gregory R Martens; Luz M Reyes; Vera Hauptfeld-Dolejsek; Matthew Tector; Joseph Tector
Journal:  Immunogenetics       Date:  2019-07-04       Impact factor: 2.846

6.  Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.

Authors:  Gregory R Martens; Luz M Reyes; Ping Li; James R Butler; Joseph M Ladowski; Jose L Estrada; Richard A Sidner; Devin E Eckhoff; Matt Tector; A Joseph Tector
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

7.  Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.

Authors:  G L Palmisano; P L Tazzari; E Cozzi; A Bolognesi; L Polito; M Seveso; E Ancona; F Ricci; R Conte; F Stirpe; G B Ferrara; M P Pistillo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 8.  Does human leukocyte antigens sensitization matter for xenotransplantation?

Authors:  Guerard W Byrne
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 9.  Aspects of histocompatibility testing in xenotransplantation.

Authors:  Joseph M Ladowski; Julie Houp; Vera Hauptfeld-Dolejsek; Mariyam Javed; Hidetaka Hara; David K C Cooper
Journal:  Transpl Immunol       Date:  2021-05-17       Impact factor: 2.032

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.